Brain, other CNS and intracranial tumours survival statistics

Coronavirus (COVID-19)

We have created a central resources hub for Health Professionals which hosts all of our CRUK resources and further materials to help with managing the pandemic. We are updating the information as guidance changes. There is also a page specifically for patients on our about cancer hub.

Health Professional COVID-19 and Cancer Hub

Survival

Survive brain tumours for 5 or more years, 2013-2017, England

Age

Age that malignant brain tumour survival is highest, 2009-2013, England

 

Improvement

Malignant brain tumour survival in the UK has doubled in the last 40 years

 

40.2% of males survive brain cancer for at least one year. This falls to 11.1% surviving for five years or more, as shown by age-standardised net survival for patients diagnosed with brain cancer during 2013-2017 in England.[1] Survival for females at one year is 39.7% and falls to 13.8% surviving for at least five years. Survival for females is similar to than for males at one year, and higher than for at five years.

Brain Cancer (C71), Age-Standardised One- and Five-Year Net Survival, Adults (Aged 15-99), England, 2013-2017

The bar chart shows one- and five-year net survival, with 95% confidence intervals. Open a glossary item
 

Ten-year survival estimates are not available for this cancer.

References

  1. Office for National Statistics, Cancer survival by stage at diagnosis for England, 2019.

About this data

Data is for England, 2013 - 2017, ICD-10 C67.

Survival statistics give an overall picture of survival and the survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Last reviewed:

Five-year survival for brain cancer is highest in the youngest men and women and decreases with increasing age. Five-year net survival in men ranges from 57% in 15-39 year-olds to 1% in 80-99 year-olds for patients diagnosed with brain cancer in England during 2009-2013.[1] In women, five-year survival ranges from 62% to 1% in the same age groups.

Brain Cancer (C71), Five-Year Net Survival by Age, England, 2009-2013

Last reviewed:

As with most cancers, survival for brain cancer is improving. One-year age-standardised Open a glossary item net survival for brain cancer in men has increased from 18% during 1971-1972 to 41% during 2010-2011 in England and Wales – an absolute survival difference Open a glossary item of 23 percentage points.[1] In women, one-year survival has increased from 18% to 39% over the same time period (a difference of 21 percentage points).

Brain Cancer (C71), Age-Standardised One-Year Net Survival, England and Wales, 1971-2011

Five- and ten-year survival has increased by a lesser amount than one-year survival since the early 1970s. Five-year age-standardised net survival for brain cancer in men has increased from 7% during 1971-1972 to a predicted survival of 18% during 2010-2011 in England and Wales – an absolute survival difference of 11 percentage points.[1] In women, five-year survival has increased from 8% to 20% over the same time period (a difference of 11 percentage points).

Brain Cancer (C71), Age-Standardised Five-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Five-year survival for 2010-2011 is predicted using an excess hazard statistical model

Ten-year age-standardised net survival for brain cancer in men has increased from 5% during 1971-1972 to a predicted survival of 13% during 2010-2011 in England and Wales - an absolute survival difference of 8 percentage points.[1] In women, ten-year survival has increased from 6% to 14% over the same time period (a difference of 8 percentage points). Overall, around 1 in 7 people diagnosed with brain cancer today are predicted to survive their disease for at least ten years.

Brain Cancer (C71), Age-Standardised Ten-Year Net Survival, Adults (Aged 15-99), England and Wales, 1971-2011

Ten-year survival for 2005-2006 and 2010-2011 is predicted using an excess hazard statistical model

References

  1. Data were provided by London School of Hygiene and Tropical Medicine on request, 2014.

About this data

Data is for: England and Wales, 1971-2011, ICD-10 C71

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, 2 Redman Place, London, E20 1JQ or

Donate online

We’re now on twitter.
Join the conversation and follow @CRUKHCPs for news, updates and opinion.

@CRUKHCPs

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.